ERC Starting Grant · 2024
Total Optical Coherence Characterization for Automated Tumor Analysis
Drug resistance, whether intrinsic or acquired during the course of treatment, is the primary cause of cancer treatment failure. Resistance is a complex and highly personalized problem, depending on tumor-specific, genetic, and other factors, but certain cancers are particularly difficult to treat. In particular, the most common and deadliest type of cancer originating in the brain, glioblastoma (GBM), is aggressive and highly resistant to treatment. Due to the complex nature of GBM, advanced methods for screening personalized treatment strategies are critically needed to improve patient outcomes. Cell spheroids are 3D tissue cultures that have proven to be a more accurate model of tumor…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.